Hospitals rarely know which step, the scanner, the biopsy, the pathologist or the clinic slot, is causing the queue. Modelling the pathway like a factory line shows where a small change would remove weeks of waiting.
Discrete-event simulation and queueing analysis are standard in manufacturing and logistics but rarely applied to cancer diagnostic pathways, where a mismatch between weekly clinic capacity and scanner slots can create long waits that no single department sees. A reusable model fed by routine timestamp data would locate the binding constraint per pathway and quantify the effect of interventions before they are made.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.
Shares Mortality due to cancer treatment delay: systematic review and meta-analysis, Fragmented care and guideline gaps.